Anti-Marijuana Groups Sue to Block Trump Administration’s Hemp CBD and THC Changes
Anti-marijuana groups have filed a hemp cbd thc lawsuit to block the Trump administration’s proposed rescheduling changes. These changes aim to reduce research barriers for hemp-derived CBD and THC products. The lawsuit could maintain current…
Military Eases Enlistment Rules for Those with Prior Marijuana Convictions – NORML
The military enlistment marijuana policy has recently eased, allowing individuals with prior marijuana convictions to serve. This change reduces barriers and reflects shifting societal views on cannabis. Clinicians should be aware of these policy updates…
Hawaii Senators Pass Resolutions Seeking Federal Medical Marijuana Exemption From DEA
Hawaii's push for a federal medical marijuana exemption aims to reduce DEA enforcement barriers for clinicians and patients. This resolution could clarify legal ambiguities and support evidence-based cannabis prescribing. The focus on federal exemption…
How Federal Funding Supports Basic Research | Face to Face with Chancellor May
Federal funding cannabis research plays a crucial role in advancing basic studies that inform clinical practice. Understanding these funding mechanisms helps identify gaps and opportunities in cannabis research. This article discusses the impact of…
The NDP has a new leader. What does Avi Lewis’s arrival mean for the party?
The ndp leadership change impact is significant with Avi Lewis taking the helm. This shift could influence the party's strategies and public perception. Understanding these changes is key for political observers.
In the Mix: 13 More Articles — March 29, 2026
This review covers 13 cannabis articles clinical relevance scores as of March 29, 2026. The articles provide insights into evolving cannabis research and policy. Clinicians will find valuable updates on cannabis clinical evidence.
Medicare CBD Regulatory Cliff: Why FDA Enforcement Must Precede Federal Reimbursement
Medicare CBD reimbursement risks highlight the need for FDA enforcement before federal coverage. Without FDA standards, clinicians face challenges prescribing safe, effective CBD. This article explains why regulatory clarity is essential for Medicare…
Chair Powell Discusses Economic Risk Management at Federal Reserve
Federal Reserve economic risk management is a critical topic discussed by Chair Powell. This article explores the implications of monetary policy decisions on healthcare economics. Understanding these risks helps contextualize broader economic impacts…
Rescheduling Cannabis Under the Controlled Substances Act | Regulatory Review
Rescheduling cannabis regulatory impact under the Controlled Substances Act could transform research and clinical practice. Lower scheduling may enable more rigorous trials and standardized product development. This shift is crucial for advancing…
Innovative Industrial Properties: Undervalued Amid Cannabis Rescheduling Milestone
The cannabis rescheduling milestone marks a pivotal change in federal law, impacting medical cannabis research and clinical practice. This shift to Schedule III could accelerate pharmaceutical development and alter regulatory frameworks. Understanding…